https://orcid.org/0000-0002-8154-2391
Figures
Abstract
Background
The preoperative diagnosis of follicular neoplasm of the thyroid is challenging due to difficulties in the assessment of capsular invasion. This study aimed to identify ultrasonographic (US) and cytopathologic features that are characteristic of follicular adenoma and carcinoma to aid in their differential diagnosis.
Methods
A total of 98 surgically resected nodules diagnosed as follicular neoplasms between 2011 and 2012 were analyzed. US findings were reviewed according to the Korean Thyroid Imaging Reporting and Data System (K-TIRADS). Six cytologic features (high cellularity, abundant microfollicles, cell crowding/nuclear overlapping, isolated cells, homogeneous nuclei, abundant colloid) were reviewed quantitatively. The radiologic findings and quantification of cytologic features were correlated with final diagnoses.
Results
In total, 70 (71.4%) and 28 (28.6%) of the nodules were follicular adenomas and follicular carcinomas, respectively. US findings of a heterogeneous echogenicity, speculated/ill-defined margin, and presence of calcifications were significantly associated with follicular carcinoma (p<0.05). Calcifications had a predilection for pericapsular areas than for stromal areas in follicular carcinomas, whereas their location was more varied in follicular adenomas. No cytologic feature was significantly different between follicular adenomas and carcinomas.
Citation: Ahn HS, Kim HS, Hong MJ (2022) Ultrasonographic and cytologic assessments of follicular neoplasms of the thyroid: Predictive features differentiating follicular carcinoma from follicular adenoma. PLoS ONE 17(7): e0271437. https://doi.org/10.1371/journal.pone.0271437
Editor: Paula Soares, Universidade do Porto Faculdade de Medicina, PORTUGAL
Received: February 4, 2022; Accepted: June 29, 2022; Published: July 21, 2022
Copyright: © 2022 Ahn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are all contained within the article.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: FNA, Fine-needle aspiration; US, Ultrasonography
Introduction
Thyroid nodules are very common, occurring in 50% of the adult population [1]. Approximately 20% of these nodules are diagnosed as follicular neoplasm on fine-needle aspiration (FNA) cytology [2]. Follicular neoplasm is a cytologic term that refers to both the benign proliferation of thyroid follicular cells in adenoma and the malignant proliferation in carcinoma [3,4]. Follicular adenomas are more common than follicular carcinomas and have no vascular or capsular invasion, but they otherwise share similar cytologic features with follicular carcinomas. In general, when a biopsy specimen of a thyroid nodule reveals a follicular neoplasm, approximately 80–90% of such lesions will be adenomas and 10–20% will be carcinomas [3,4]. Given these shared features, cytological differentiation between benign and malignant tumors is challenging [5]. Cytologic specimens cannot be histologically evaluated for capsular invasion. Moreover, some cases of frozen section specimen as well as core needle biopsy also cannot differentiated follicular adenoma between carcinoma because nodular capsule has not to be completely examined; thus, surgical excision such as lobectomy is recommended to aid in the diagnosis of follicular carcinoma and follicular adenoma, although this is highly invasive method [6,7].
Some studies have proposed ultrasonographic (US) findings and cytologic features to differentiate follicular carcinoma from adenoma [8–11]. Retrospective studies have reported the predictive usefulness of US findings for follicular carcinoma [8–10]. A recent pathologic study analyzed the utility of various cytologic features to increase the accuracy of cytologic diagnosis for follicular neoplasm [11]. However, no distinct findings characteristic of benign and malignant follicular neoplasms have been established. Thus, this study aimed to identify US findings and cytopathological features that can aid in the differential diagnosis between follicular adenoma and carcinoma.
Materials and methods
Study design and specimens
This retrospective study was approved by the appropriate Institutional Review Board at Chung-Ang University Hospital (2107-016-470) and informed consent was not required because it’s retrospective nature of the study.
A total of 120 patients with thyroid nodules who underwent surgical resection and diagnosed with follicular neoplasms between January 2011 and December 2012 were evaluated. Of these, 22 were excluded because of unavailable FNA result or FNA performed elsewhere (n = 15) and limited evaluation of US images due to outside US examination (n = 7). Finally, 98 nodules of 98 patients who initially diagnosed via FNA procedures and finally diagnosed by surgical resection were analyzed.
US imaging and procedures
Thyroid US examination and procedures were performed by one of two experienced radiologists with 8 and 7 years of thyroid imaging experience, respectively. US examination was performed using high-resolution US equipment with a 12 MHz linear transducer (IU 22; Philips Ultrasound, Bothell, Washington, USA). US-guided FNA was performed using a conventional method, and at least two samples were taken per nodule. FNA was conducted using a 23-gauge needle attached to a 5-ml syringe. Successful sampling was achieved with numerous multidirectional passes through the nodule. Specimens were preserved in bottles with 95% ethanol for liquid-based cytological examination (Surepath). Repeat FNA was considered in cases of non-diagnostic cytological findings of nodules or atypia/follicular lesions of undetermined significance (AUS/FLUS).
Radiologic and cytopathologic analyses
Radiologic and cytopathologic data of the 98 thyroid nodules were collected. Two experienced radiologists (HSA and MJH, who had 8 and 9 years of experience in performing thyroid US and interventional procedures, respectively) blinded to the FNA results or final diagnoses retrospectively reviewed the US images in consensus. The US features included size, composition, margin, echogenicity, orientation, and calcifications, and the nodules were categorized according to the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) guideline developed by The Korean Society of Thyroid Radiology [12]. The thyroid nodules were categorized into four categories (benign, low suspicion, intermediate suspicion, and high suspicion) using the K-TIRADS, a malignancy risk-stratification system developed based on solidity, echogenicity, and suspicious US features in thyroid nodule. K-TIRADS 5(high suspicion) nodules include solid hypoechoic nodules with any suspicious US feature (microcalcification, non-parallel orientation, spiculated/microlobulated margin). K-TIRADS 4 (intermediate suspicion) nodules include solid hypoechoic nodules without suspicious US feature and partially cystic or iso-hyperechoic nodules with any suspicious US feature. K-TIRADS 3 (low suspicion) nodules include partially cystic or iso- or hyperechoic nodules with no suspicious US feature. K-TIRADS 2 (benign) nodules include pure cysts, partially cystic with comet tail artifacts, and spongiform nodules. In particular, the calcifications are categorized as microcalcifications (punctuate echogenic foci of 1 mm or less either with or without posterior shadowing), macrocalcifications (echogenic foci greater than 1 mm in size with posterior shadowing), and rim calcifications (peripheral curvilinear or eggshell calcification at the nodule margin).
Cytopathologic findings were retrospectively reviewed by a thyroid pathologist with 20 years of experience (HSK). The interpretation of FNA was based on The Bethesda System for Reporting Thyroid Cytopathology [13]. FNA cytology results were classified as six categories of Bethesda System. In addition, the following six cytologic features were quantitatively reviewed: high cellularity, abundant microfollicles, cell crowding/nuclear overlapping, isolated cells, homogeneous nuclei, and abundant colloid. These were then classified into five categories based on previous literature by Yoo et al [11]: 0 (absent, 0%), 1, (minimal, <10%), 2 (mild, 10–40%), 3 (moderate, 41–70%), and 4 (marked, >70%). Each feature was summarized as a score and statistically compared with the Bethesda categorization and final diagnoses. Every cytologic feature is represented in Fig 1. For the cases in which multiple FNA (up to 2 times) was performed, the highest grade of cytologic diagnosis was selected.
(a) High cellularity (×40). (b) Abundant microfollicles (×100). (c) Cell crowding and nuclear overlapping (×400). (d) Isolated cells (×100). (e) Abundant colloids (×40). (f) Homogeneous nuclei (×400).
Reference standard and statistical analysis
The final surgical histopathologic findings of either total thyroidectomy or lobectomy were used as the reference standard (follicular adenoma vs. follicular carcinoma). The radiologic K-TIRADS findings and the quantified cytologic features were correlated with final diagnoses. Between-group comparisons of continuous variables, including age and nodule size, were conducted using the two sample t-test, while categorical variables were compared using the chi-square test and Fisher’s exact test. The quantified cytologic features were dichotomized as mild for 0, 1, and 2 and severe for 3 and 4 for chi-square or Fisher’s exact test. All statistical analyses were performed using commercially available statistical software (SPSS, version 20.0; SPSS, Chicago, IL). Significance was defined as p<0.05.
Results
Patient and nodule characteristics
The mean patient age was 50.8 ± 14.4 years, and most patients were female (n = 74 (75.5%); male, n = 24, 24.5%). Among the 98 thyroid nodules, 70 and 28 were follicular adenomas and follicular carcinomas, respectively. The lesion diameter on B-mode US ranged from 0.5 cm to 5.4 cm (mean: 1.9 cm). All diagnoses were surgically confirmed by total thyroidectomy (n = 62) or lobectomy (n = 36) (Table 1). Overall, 25 of the 98 nodules were subjected to multiple FNA. On the first FNA, 10 nodules were non-diagnostic (Bethesda I); 10 nodules, benign (Bethesda II); 33 nodules, AUS/FLUS (Bethesda III); 43 nodules, suspicious for follicular neoplasm/ follicular neoplasm (SFN/FN; Bethesda IV); and 2 nodules, papillary thyroid carcinoma (Bethesda VI). On the second FNA of 23 nodules, 4, 7, 4, and 8 nodules were categorized as non-diagnostic (Bethesda I), benign (Bethesda II), AUS/FLUS results (Bethesda III), and SFN/FN (Bethesda IV), respectively. On the third FNA of 2 nodules, 1 nodule was categorized as nondiagnostic (Bethesda I), while the other, benign (Bethesda II). The mean time span between first and second FNA was 93 days (range, 81 days to 105 days), between second and third FNA was 85 days (range, 77 days to 90 days). The mean time duration between final FNA of each nodules and surgical resection was 10 days (range, 7 days to 17 days).
Radiographic and cytopathologic features
Among the six cytologic features evaluated, follicular adenomas and carcinomas shared features of high cellularity, abundant microfollicles, cell crowding/nuclear overlapping, and homogeneous nuclei and lack of isolated cells and abundant colloid. There were no significant differences in cytologic features between the follicular neoplasms (all p>0.05) (Table 2).
Meanwhile, there were distinct sonographic features between the two follicular neoplasms. Heterogeneous echogenicity was more common in follicular carcinomas (28.6% vs. 11.4%, p = 0.042). Follicular carcinomas also more frequently showed an ill-defined margin (14.3% vs. 2.9%), whereas follicular adenomas more commonly had a smooth margin (97.1% vs. 82.1%) (p = 0.027). Calcifications were also more common in follicular carcinomas (35.7% vs. 14.3%, p = 0.048), with macrocalcification being the most frequent type (25%, 7/28). Macro- and rim calcifications were observed in 32.1% of follicular carcinomas, but only in 10.0% of follicular adenomas. Other US findings of nodule size, composition, echogenicity, orientation, shape, and K-TIRADS category were not significantly different between follicular carcinomas and adenomas. The sonographic features of follicular adenomas and carcinomas are presented in Table 3.
The characteristics of the cases with nodule calcifications are shown in Table 4. With respect to location, calcifications were limited to the stromal (n = 3) or pericapsular (n = 7) area in follicular carcinomas. Meanwhile, it was more varied in follicular adenoma: follicular, 4 cases; stromal, 3 cases; and pericapsular, 3 cases. The calcifications were most frequently located in the follicle for follicular adenoma and in the pericapsule for follicular carcinoma (Figs 2 and 3).
A 59-year-old man was diagnosed with follicular adenoma on US. (a) An US image showing a 4.6 cm–sized oval predominantly solid isoechoic nodule with internal microcalcification. (b) US-guided FNA is performed with a 21-gauge syringe, and the nodule is suspicious for a follicular neoplasm. (c) The surgical specimen shows microfollicular proliferation with one macrofollicle containing three pieces of intrafollicular calcification corresponding to the ultrasonographic image shown in Fig 2A (arrows). ×40 original magnification. Hematoxylin and eosin staining is used. US, ultrasonography; FNA, fine-needle aspiration.
A 66-year-old woman was diagnosed with widely invasive follicular carcinoma. (a) An US image showing a 2.9 cm-sized heterogeneous ill-defined solid hypoechoic nodule with internal macrocalcification. (b) US-guided FNA is performed with a 21-gauge syringe, and the nodule appears to be a follicular lesion of undetermined significance. (c) The surgical specimen shows microfollicular proliferation with thick fibrous capsule with large pericapsular calcification corresponding to US image shown in Fig 3A (arrows). ×12.5 original magnification. Hematoxylin and eosin staining is used. US, ultrasonography; FNA, fine-needle aspiration.
Discussion
Imaging features characteristic of benign and malignant follicular neoplasms have not been established. This study found that US features of heterogeneous echogenicity, spiculated/ill-defined margin, and presence of calcification are more common in follicular carcinoma than in follicular adenoma. Thus, they may be useful in the pathological diagnosis of follicular neoplasm before surgery.
Follicular neoplasms are challenging to classify cytologically because cytologic specimens cannot be histologically evaluated for capsular invasion. Therefore, recent guidelines recommend diagnostic surgery for patients with FN/SFN findings [7,14,15]. However, given that surgery is highly invasive, several studies have attempted to analyze cytologic features predictive of malignancy. Park et al. reported that atypism, which reveals higher anisocytosis, nuclear pleomorphism, coarse clumping of chromatin, and cellular overlapping, is more frequent in follicular carcinoma [16].
Another study reported that follicular neoplasm is characterized by the abundance of follicular epithelial cells, the presence of microfollicular structures, abundant cell crowding, abundant dispersed isolated cells, homogenous nuclear morphology, the lack of nuclear grooves, the lack of colloid material, and the lack of macrophages on cytology, making FNA a useful tool for differentiating follicular neoplasms [11]. However, in the current study, all six cytologic features reviewed (high cellularity, abundant microfollicles, cell crowding/nuclear overlapping, isolated cells, homogeneous nuclei, and abundant colloid) did not show significant differences between benign and malignant tumors. This is probably due to the limited evaluation of architectural histologic structures, including the nodule capsule.
Many retrospective studies have described the features of follicular neoplasm on US imaging. Although some of these studies reported that US had no diagnostic value in distinguishing follicular carcinoma from follicular adenoma [17,18], several studies have demonstrated its predictive capability for follicular carcinoma [19–24]. Zhang et al. reported that a US finding of heterogeneous echotexture is significantly associated with follicular carcinoma [19]. Another study by Shin et al. suggested a higher frequency of heterogeneous mulberry-like echotexture in invasive follicular thyroid carcinoma than in minimally invasive follicular carcinoma [20]. The heterogeneous echotexture may be due to tissue necrosis and/or hemorrhage within follicular carcinomas [19–21]. Another predictive feature is the lesion margin on US [22,23]. Pompili et al. proposed a scoring system for malignancy in cytologically diagnosed follicular lesions and reported that an irregular margin of the nodule is significantly correlated with malignancy [22]. Another recent study reported that spiculated margin on US is a predictive feature of follicular carcinoma [23].
Consistent findings were found in the current study. In addition, we identified that the presence of calcification within the nodule is significantly predictive of follicular carcinoma. While calcifications are more common in papillary thyroid carcinoma, they can be seen in follicular carcinomas. Grani et al. reported microcalcifications which suggestive of psammoma bodies are common in papillary thyroid cancer, whereas rim and coarse calcification can be found in both follicular and papillary thyroid cancer, probably due to necrosis and hemorrhage [25]. Our result in terms of calcifications is concordant with other previous studies [22–24]. In these studies, the presence of calcification accurately predicted malignancy, with odds ratios of 6.413–22.879 [22–24]. Shin et al. compared the US findings between widely and minimally invasive follicular thyroid carcinoma and found a higher frequency of calcifications in widely invasive follicular carcinoma [20]. Authors also reported that ring calcification is the most common type of calcification in invasive follicular carcinoma, and it arises from dystrophic calcifications deposited along intervening capsules. Zhang et al. a higher frequency of micro-/macro-calcifications and peripheral calcifications in follicular carcinoma than in follicular adenoma and suggested that these calcifications may be secondary to tissue necrosis, hemorrhage, or dystrophic changes [19].
In our study, we evaluated the US features of calcification and the location of calcification on the final pathology specimen. The results showed that macro- and rim calcifications were more common in follicular carcinoma (32.1%, 9/28), and 7 of 10 follicular carcinomas showed pericapsular location on final pathology. To the best of our knowledge, our study is the first to describe and differentiate the location of calcification on pathologic specimens in follicular neoplasms. The findings support the fact that US features of follicular neoplasms and the characteristics/locations of calcifications on thyroid nodules have a potential value to predict follicular carcinoma. Collectively, our data and those of previous studies support that US findings of spiculated/ill-defined margins, heterogeneity, and macro-/rim calcifications can help differentiate follicular carcinoma from follicular adenoma. In addition, the location of calcifications on final pathology may distinguish between follicular adenoma and carcinoma.
Our study has some limitations. The retrospective study design is associated with an unavoidable selection bias. The study design also prevented us from evaluating US findings in real time, which might have influenced the evaluation of the reviewers. In addition, surgery is not a common diagnostic modality for follicular neoplasms. Thus, our inclusion of only patients who have underwent surgery led to a small sample size. However, this bias is unavoidable because histopathology is necessary to establish the final diagnosis.
In conclusion, no cytologic feature is significantly different between follicular adenomas and carcinomas. However, US findings of a heterogeneous echogenicity, speculated/ill-defined margin, and presence of macro-/rim calcifications are characteristic of follicular carcinomas. Thus, these characteristics may be helpful in a preoperative diagnosis for a difficult case as determined by FNA in clinical suspected follicular neoplasm.
References
- 1. Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US Features of thyroid malignancy: pearls and pitfalls. Radiographics: a review publication of the Radiological Society of North America, Inc. 2007;27(3):847–60; discussion 61–5. pmid:17495296.
- 2. Carling T, Udelsman R. Follicular neoplasms of the thyroid: what to recommend. Thyroid: official journal of the American Thyroid Association. 2005;15(6):583–7. pmid:16029125.
- 3. Smith J, Cheifetz RE, Schneidereit N, Berean K, Thomson T. Can cytology accurately predict benign follicular nodules? American journal of surgery. 2005;189(5):592–5; discussion 5. pmid:15862502.
- 4. Carpi A, Nicolini A, Gross MD, Fig LM, Shapiro B, Fanti S, et al. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2005;59(9):517–20. pmid:16202555.
- 5. Bhasin TS, Mannan R, Manjari M, Mehra M, Gill Sekhon AK, Chandey M, et al. Reproducibility of ’The Bethesda System for reporting Thyroid Cytopathology’: A MultiCenter Study with Review of the Literature. Journal of clinical and diagnostic research: JCDR. 2013;7(6):1051–4. pmid:23905101; PubMed Central PMCID: PMC3708196.
- 6. Ugurluoglu C, Dobur F, Karabagli P, Celik ZE. Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients. International journal of clinical and experimental pathology. 2015;8(11):14800–5. pmid:26823807; PubMed Central PMCID: PMC4713593.
- 7. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid: official journal of the American Thyroid Association. 2017;27(11):1341–6. pmid:29091573.
- 8. Sillery JC, Reading CC, Charboneau JW, Henrichsen TL, Hay ID, Mandrekar JN. Thyroid follicular carcinoma: sonographic features of 50 cases. AJR American journal of roentgenology. 2010;194(1):44–54. pmid:20028904.
- 9. Seo HS, Lee DH, Park SH, Min HS, Na DG. Thyroid follicular neoplasms: can sonography distinguish between adenomas and carcinomas? Journal of clinical ultrasound: JCU. 2009;37(9):493–500. pmid:19746451.
- 10. Hagag P, Strauss S, Weiss M. Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid: official journal of the American Thyroid Association. 1998;8(11):989–95. pmid:9848711
- 11. Yoo C, Choi HJ, Im S, Jung JH, Min K, Kang CS, et al. Fine needle aspiration cytology of thyroid follicular neoplasm: cytohistologic correlation and accuracy. Korean journal of pathology. 2013;47(1):61–6. pmid:23483732; PubMed Central PMCID: PMC3589610.
- 12. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean journal of radiology. 2016;17(3):370–95. pmid:27134526; PubMed Central PMCID: PMC4842857.
- 13. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid: official journal of the American Thyroid Association. 2009;19(11):1159–65. pmid:19888858.
- 14. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid: official journal of the American Thyroid Association. 2016;26(1):1–133. pmid:26462967; PubMed Central PMCID: PMC4739132.
- 15. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules—2016 Update. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2016;22(5):622–39. pmid:27167915.
- 16. Park HD PW, Kim SH. Cytologic features of follicular adenoma and follicular carcinoma of the thyroid: a study on the likelihood of cytologic diagnosis by fine needle aspiration cytology. Korean J Cytopathol 2008;19:7.
- 17. Koike E, Noguchi S, Yamashita H, Murakami T, Ohshima A, Kawamoto H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Archives of surgery. 2001;136(3):334–7. pmid:11231857.
- 18. Rago T, Di Coscio G, Basolo F, Scutari M, Elisei R, Berti P, et al. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clinical endocrinology. 2007;66(1):13–20. pmid:17201796.
- 19. Zhang JZ, Hu B. Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma. Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine. 2014;33(2):221–7. pmid:24449724.
- 20. Shin JH, Han BK, Ko EY, Oh YL, Kim JH. Differentiation of widely invasive and minimally invasive follicular thyroid carcinoma with sonography. European journal of radiology. 2010;74(3):453–7. pmid:19369019.
- 21. Sobrinho-Simoes M, Eloy C, Magalhaes J, Lobo C, Amaro T. Follicular thyroid carcinoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2011;24 Suppl 2:S10–8. pmid:21455197.
- 22. Pompili G, Tresoldi S, Primolevo A, De Pasquale L, Di Leo G, Cornalba G. Management of thyroid follicular proliferation: an ultrasound-based malignancy score to opt for surgical or conservative treatment. Ultrasound in medicine & biology. 2013;39(8):1350–5. pmid:23743097.
- 23. Kuo TC, Wu MH, Chen KY, Hsieh MS, Chen A, Chen CN. Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma. Asian journal of surgery. 2020;43(1):339–46. pmid:31182260.
- 24. Lee EK, Chung KW, Min HS, Kim TS, Kim TH, Ryu JS, et al. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. Journal of Korean medical science. 2012;27(9):1014–8. pmid:22969246; PubMed Central PMCID: PMC3429817.
- 25. Grani G, Lamartina L, Durante C, Filetti S, Cooper DS. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 2018;6(6):500–14. Epub 2017/11/06. pmid:29102432.